Monthly Archives: April 2020

SHAREHOLDER ALERT: TUFN ANAB HAFC: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

NEW YORK, NY / ACCESSWIRE / April 30, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

Tufin Software Technologies Ltd. (NYSE: TUFN)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/tufin-software-technologies-ltd-loss-submission-form?prid=6266&wire=1
Lead Plaintiff Deadline: June 5, 2020
Class Period: securities pursuant and/or traceable to the registration statement and related prospectus issued in connection with Tufin's April 2019 initial public offering

Allegations against TUFN include that: (1) Tufin's customer relationships and growth metrics were overstated, particularly with respect to North America; (2) Tufin's business was deteriorating, primarily in North America; (3) as a result, Tufin's representations regarding its sustainable financial prospects were overly optimistic; and (4) as a result, the Offering Documents were materially false and/or misleading and failed to state information required to be stated therein.

AnaptysBio, Inc. (NASDAQ: ANAB)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/anaptysbio-inc-loss-submission-form?prid=6266&wire=1
Lead Plaintiff Deadline: May 26, 2020
Class Period: October 10, 2017 to November 7, 2019

Allegations against ANAB include that: (i) AnaptysBio failed to disseminate important data from the Company's Phase 2a trial in atopic dermatitis, including the timing and extent of patients' use of topical corticosteroids as a rescue therapy during the study and whether any of the patients that utilized rescue therapy were classified as responders at a given time;and (ii) the Company's statements omitted key information from the Company's Phase 2a trial in peanut allergy, including patients' average cumulative peanut dose tolerated at day 14 after the administration of etokimab or placebo as well as whether the Company's decision to exclude 20% of the patients enrolled in the study from the interim analysis due to their mild symptoms was retrospective; and (ii) as a result of the foregoing, Defendants' positive statements about the efficacy and prospects of AnaptysBio's lead drug asset in the treatment of atopic dermatitis and peanut allergy were materially false and/or misleading and/or lacked a reasonable basis.

Hanmi Financial Corporation (NASDAQ: HAFC)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/hanmi-financial-corporation-loss-submission-form?prid=6266&wire=1
Lead Plaintiff Deadline: May 26, 2020
Class Period: August 12, 2019 to January 28, 2020

Allegations against HAFC include that: (1) the $40.7 million troubled loan that the Company disclosed on conference calls would necessitate further and future specific provisions for the Company – in the millions; (2) the same $40.7 million troubled loan would necessitate the Company to appraise and take personal property securing a portion of the amount of the loan; and (3) as a result, Defendants' public statements were materially false and misleading at all relevant times.

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong

ReleaseID: 587741

Bill Lerner – Discusses the Roots of the Parking Industry in New York City

New York City has always been one of the main epicenters of parking innovation

New York, NY – April 30, 2020 /MarketersMedia/

Bill Lerner understands quite well the rich history of parking in New York City. Lerner is the founder of the biggest privately owned parking company in New York, with a strong expertise in the development of garages. For Lerner, parking has always been a family trade, beginning with his father’s ownership of several properties in the 1960s and 70s. By the time he entered the industry in 1978, there were 12 locations managed by Imperial Parking, the original name of the company. Today, iPark is responsible for over 130 garages in the New York area, with more on the horizon.

New York City has always been one of the main epicenters of parking innovation, as the popularity of the automobile in urban areas rose substantially upon introduction. By 1929, over 23 million cars were driving on American roads, creating a rapidly growing problem in major cities. The issue continued to worsen over the coming decades as cities struggled to accommodate the massive influx of these vehicles. Lerner’s father operated a gas station and adjacent parking lot during the 1940s and 50s, and quickly recognized the opportunity. “That’s where he saw the need for parking in the city of New York, when people came to work during the day,” Lerner said to The Atlantic. “Especially after World War II, when all the G.I.s were coming back from Europe and they had learned to drive Jeeps while over in Europe. They were given money by the government under the G.I. Bill…it really created a need to have garages in New York.”

The city’s earliest parking garages were much more regal than today’s versions, operating as fully enclosed buildings that often included professional attendants who handled the parking for the customer. Some even contained a fully staffed gas-and-service station, and others provided babysitting while drivers shopped nearby. By the 1950s, New York City was in the midst of a construction boom for parking garages, and self-service eventually became the norm. Innovations in building design, materials, and vehicle durability eventually led to the open-air, concrete structures that are now standard. Leading the industry into the new era, Bill Lerner is embracing modern technological changes in a variety of ways, including the offering of electric charging stations at select locations.

Bill Lerner is the President and CEO of iPark, New York’s largest family-owned parking garage entity. Upon graduating from the University of Colorado with a degree in Business, Bill officially joined his family’s company, where he began to strategically redevelop its operational processes. Today, he personally oversees all technological transitions, placing iPark at the forefront of the parking industry’s evolution as the company further expands into new locations. A philanthropist at heart, Bill devotes his spare time to a number of charitable causes, most notably Billy4Kids; a nonprofit organization he founded that works to provide shoes for underprivileged children around the world.

Bill Lerner – President and CEO of iPark: http://billlernernews.com

Billy Lerner (@billy_lerner) – Twitter: https://twitter.com/billy_lerner

Billy Lerner – Home – Facebook: https://www.facebook.com/billylernerofficial/

Contact Info:
Name: BLN
Email: Send Email
Organization: BillLernerNews.com
Website: http://billlernernews.com

Source URL: https://marketersmedia.com/bill-lerner-discusses-the-roots-of-the-parking-industry-in-new-york-city/88955229

Source: MarketersMedia

Release ID: 88955229

NeoGenomics Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes

FORT MYERS, FL / ACCESSWIRE / April 30, 2020 / NeoGenomics, Inc. (NASDAQ:NEO) (the "Company"), a leading provider of cancer-focused genetics testing services, today announced the pricing of concurrent underwritten public offerings of (a) 4,400,000 shares of its common stock at a public offering price of $28.50 per share for gross proceeds to NeoGenomics from the offering of $125.4 million, before deducting the underwriting discounts and commissions and estimated offering expenses payable by NeoGenomics (the "common stock offering") and (b) $175,000,000 aggregate principal amount of its 1.25% convertible senior notes due 2025 (the "notes") (the "notes offering") for gross proceeds to NeoGenomics from the offering of $175.0 million, before deducting the underwriting discounts and commissions and estimated offering expenses payable by NeoGenomics. In addition, NeoGenomics has granted the underwriters a 30-day option to purchase an additional (a) 660,000 shares of common stock at the public offering price, less underwriting discounts and commissions, and (b) $26,250,000 aggregate amount of notes at the public offering price, less underwriting discounts and commissions and solely to cover over-allotments with respect to the notes offering. The size of the common stock offering and the notes offering were each increased from the previously announced amounts. The underwriters of the common stock offering are also offering 1,065,000 shares of NeoGenomics common stock borrowed from third parties (the "short sale") and will use the resulting short position to facilitate hedging transactions by some of the purchasers of the notes. The notes offering and the short sale are contingent upon one another. The offerings of the shares and the notes are expected to close on or about May 4, 2020, subject to the satisfaction of customary closing conditions.

The notes will be senior, unsecured obligations of NeoGenomics, and will bear interest at a rate of 1.25% per year. Interest will be payable semi-annually in arrears on May 1 and November 1 of each year, beginning on November 1, 2020. The notes will mature on May 1, 2025, unless earlier repurchased or converted.

The notes may be converted at an initial conversion rate of 27.5198 shares of NeoGenomics' common stock per $1,000 principal amount of notes (which is equivalent to an initial conversion price of approximately $36.34 per share and represents a conversion premium of approximately 27.5% to the public offering price of NeoGenomics' common stock in the common stock offering). Prior to the close of business on the business day immediately preceding February 1, 2025, the notes will be convertible at the option of the holders of the notes only upon the satisfaction of specified conditions and during certain periods. On or after February 1, 2025 until the close of business on the business day preceding the maturity date, the notes will be convertible at the option of the holders of notes at any time regardless of these conditions. Conversions of the notes will be settled in cash, shares of NeoGenomics' common stock or a combination thereof, at NeoGenomics' election.

NeoGenomics may redeem all or any portion of the notes, at its option, on or after May 6, 2023, at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest thereon, if the last reported sale price of NeoGenomics' common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which NeoGenomics provides written notice of redemption.

Holders of notes may require NeoGenomics to repurchase their notes upon the occurrence of certain events that constitute a fundamental change under the indenture governing the notes at a purchase price equal to 100% of the principal amount thereof, plus accrued and unpaid interest to, but excluding, the date of repurchase. In connection with certain corporate events or if NeoGenomics issues a notice of redemption, it will, under certain circumstances, increase the conversion rate for holders who elect to convert their notes in connection with such corporate event or during the relevant redemption period.

Morgan Stanley, BofA Securities, and SVB Leerink acted as representatives of the underwriters and book-running managers for the offerings. William Blair, Craig-Hallum Capital Group, Needham & Company, and Raymond James acted as co-managers for the offerings.

NeoGenomics intends to use the net proceeds from the offerings for general corporate purposes and to repay borrowings under its term loan facility. NeoGenomics may use a portion of the net proceeds to acquire or invest in complementary businesses and technologies.

An automatic shelf registration statement (including a prospectus) relating to the notes offering was filed with Securities Exchange Commission ("SEC") on April 29, 2020 and became effective upon filing and is available on the SEC's website at www.sec.gov. An automatic shelf registration statement (including a prospectus) relating to the common stock offering was filed with the SEC on May 20, 2019 and became effective upon filing and a preliminary prospectus supplement related to the common stock offering and accompanying preliminary prospectus relating to the common stock offering and short sale has been filed with the SEC and is available on the SEC's website at www.sec.gov. Alternatively, copies of the notes offering preliminary prospectus and the common stock offering preliminary prospectus supplement and the related final prospectus and prospectus supplement, when available, may be obtained from: Morgan Stanley & Co. LLC, Attn: Prospectus Department, 180 Varick Street, 2nd Floor, New York , NY 10014; BofA Securities, NC1-004-03-43, 200 North College Street, 3rd Floor, Charlotte, NC 28255-0001, Attn: Prospectus Department or email: dg.prospectus_requests@bofa.com; or SVB Leerink LLC, Attention: Syndicate Department, One Federal Street, 37th Floor, Boston, MA 02110, telephone: 1-800-808-7525 ex. 6218 or email: syndicate@svbleerink.com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities, in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction. The offerings are being made only by means of the prospectus for the notes offering and the prospectus supplement and the accompanying prospectus for the common stock offering and short sale.

About NeoGenomics, Inc.

NeoGenomics, Inc. specializes in cancer genetics testing and information services. The Company provides one of the most comprehensive oncology-focused testing menus in the world for physicians to help them diagnose and treat cancer. The Company's Pharma Services Division serves pharmaceutical clients in clinical trials and drug development.

Headquartered in Fort Myers, FL, NeoGenomics operates CAP accredited and CLIA certified laboratories in Ft. Myers and Tampa, Florida; Aliso Viejo, Carlsbad, Fresno and San Diego, California; Houston, Texas; Atlanta, Georgia; Nashville, Tennessee; and CAP accredited laboratories in Rolle, Switzerland, and Singapore. NeoGenomics serves the needs of pathologists, oncologists, academic centers, hospital systems, pharmaceutical firms, integrated service delivery networks, and managed care organizations throughout the United States, and pharmaceutical firms in Europe and Asia.

Forward Looking Statements

Certain statements contained in this press release that are not historical, including but not limited to those regarding NeoGenomics' planned offerings of common stock and short sale and convertible senior notes and anticipated use of the net proceeds, constitute forward-looking statements for purposes of the safe harbor provisions of The Private Securities Litigation Reform Act of 1995. These forward-looking statements involve a number of risks and uncertainties that could cause actual future results to differ materially from those anticipated in the forward-looking statements. No assurance can be given that the offerings will be consummated on the terms described above or at all. Consummation of the offerings and the terms thereof are subject to numerous conditions, many of which are beyond the control of the NeoGenomics, including: the prevailing conditions in the capital markets; interest rates; and economic, political and market factors affecting trading volumes, securities prices or demand for the Company's securities. As a result, this press release should be read in conjunction with the NeoGenomics' periodic filings with the SEC and the offering documents for the notes offering and the common stock offering and short sale.

For a discussion of risks and uncertainties, which could cause actual results to differ materially from those contained in the forward-looking statements, see "Risk Factors" in the NeoGenomics' Annual Report on Form 10-K, for the most recently ended fiscal year and in its Quarterly Report on Form 10-Q filed with the SEC on April 29, 2020, and the notes offering preliminary prospectus and common stock offering preliminary prospectus supplement filed with the SEC on April 29, 2020.

For further information, please contact:

NeoGenomics, Inc.
William Bonello
Director, Investor Relations
(239) 690-4238 (w)
(239) 284-4314 (m)
bill.bonello@neogenomics.com

SOURCE: NeoGenomics, Inc.

ReleaseID: 587739

Cyren Schedules First Quarter 2020 Earnings Release for Wednesday, May 13, 2020

MCLEAN, VA / ACCESSWIRE / April 30, 2020 / Cyren (NASDAQ:CYRN) today announced it will release its first quarter 2020 results on Wednesday, May 13, 2020, before U.S. markets open.

The company will also host a conference call at 10 a.m. Eastern Time (5 p.m. Israel Time) on Wednesday, May 13, 2020.

US: 1-877-407-0312

Israel: 1-80-940-6247

International: 1-201-389-0899

The call will be simultaneously webcast live on the investor relations section of Cyren's website at http://ir.cyren.com, or by using the following link: https://webcasts.eqs.com/cyren20200513/en.

For those unable to participate in the live conference call, a replay will be available until May 27, 2020. To access the replay, the U.S. dial-in number is 1-877-660-6853 and the non-U.S. dial-in number is 1-201-612-7415. Callers will be prompted for replay conference ID number 13703081. An archived version of the webcast will also be available on the investor relations section of the company's website at http://ir.cyren.com/events.

About Cyren

More than 1.3 billion users around the world rely on Cyren's 100% cloud security solutions to protect them against cyberattacks and data loss every day. Powered by the world's largest security cloud, Cyren (NASDAQ: CYRN) delivers fast time-to-protection with award-winning email security, cloud sandboxing and DNS filtering services for business, and threat intelligence solutions for service providers and security vendors like Microsoft, Google and Check Point. Learn more at www.cyren.com.

Blog: blog.cyren.com
Facebook: www.facebook.com/CyrenWeb
LinkedIn: www.linkedin.com/company/cyren
Twitter: www.twitter.com/CyrenInc

Company Contact:

Mike Myshrall, CFO
Cyren
+1.703.760.3320
mike.myshrall@cyren.com

SOURCE: Cyren via EQS Newswire

ReleaseID: 587471

GreenBox POS Opens Real Time Payment Technology to All Clients

SAN DIEGO, CA / ACCESSWIRE / April 30, 2020 / GreenBox POS (OTC PINK:GRBX)("GreenBox")(the "Company") is pleased to announce it is making its Real Time Payment (RTP) technology available to all clients. GreenBox believes that worldwide demand for RTP technology is experiencing an exponential demand; GreenBox is ready to respond. In response to perceived demand in European markets, GreenBox chose to seek to modify its payment technologies, and other client services in response.

How this groundbreaking service works: GreenBox's technology allows clients to utilize their debit cards to "push" funds directly into their checking account. In most cases, funds appear in the client's checking account within seconds. Although functionality depends on the ability of an individual's financial institution, GreenBox has reason to believe that in most cases that this technology works 24/7 on their ecosystem and their clients' ledger is updated in real-time. GreenBox proudly reports that it depends nor operate on regular banking hours.

Stranded for gas with no funds in your checking account? Sunday and you cannot deposit that check? Restaurant manager forced to stop a shift and payout tips in cash? With GreenBox's revolutionary, innovative, secure, real-time push payment disbursement program, this is a problem of the past.

"We believe in the Time Value of Money concept at GreenBox," said Fredi Nisan, CEO of GreenBox. "We have seen that delivering funds faster to our clients allows for their better cash flow, faster inventory replenishment and ultimately more transactions on our platform. Real-time payments are the future. Waiting for money is no longer acceptable option for our clients. This is the future of payments, made available now."

About GreenBox POS:

GreenBox POS ("GRBX", "GreenBox") is a groundbreaking technology company that builds customized payment solutions for a variety of industries. GreenBox develops individual disruptive applications integrated in an end-to-end suite of financial products, supporting multitude of industries with an emphasis on Blockchain secured ledger technology. A main business focus is in blockchain ledgering services, capable of handling large commercial processing volumes for its merchant clients in myriad of business verticals. GreenBox is now capable of managing both legacy currency transactions as well as crypto payouts. GreenBox's main operating geography remains the USA, with additional capacity, clientele and technology availability developing in other countries.

For more information, visit the Company's website at https://www.greenboxpos.com/

Forward-Looking Statements Disclaimer:

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the Company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the Company's SEC filings. These risks and uncertainties could cause the Company's actual results to differ materially from those indicated in the forward-looking statements.

Public Relations and Media Contact:

GreenBox POS
www.GreenBoxPOS.com
Office: 619-631-4838
Info@GreenBoxPOS.com

SOURCE: GreenBox POS

ReleaseID: 587733

Disability Tax Credit Calculator Canada Financial Freedom Award Launched

A disability tax credit helpline has been launched for housebound Canadians who want to see progress in their cases. Canada Benefit Group is providing its resources to help people via the helpline.

Mount Royal, Canada – April 30, 2020 /PressCable/

The Canada Benefit Group has launched a disability tax credit calculator for all Canadians in all provinces and territories who may be eligible to receive thousands of dollars in benefits. This gives clients who qualify more financial freedom and allows them to live better lives. They pride themselves in treating each client like family and not just another application.

For more information https://canadabenefit.ca

The launch of a disability tax credit calculator by Canada Benefit group was developed to assist those suffering from delays in their cases. With the many restrictions of public exposure and travel, they want each client to know they are important and valuable. They are currently available to help in Ontario, Quebec, Newfoundland, British Columbia, Alberta, PEI, Manitoba, New Brunswick, and Saskatchewan.

The Government of Canada through the Canada Revenue Agency (CRA) offers various tax refunds and benefits for individuals with disabilities. These benefits are provided for Canadians with many different types of health issues.

The firm takes great pride in providing their clients with first-class customer service and ensures that they receive the maximum amount of benefits in the shortest period.

Since 2015 they have over 1500 successful clients garnering over $6 million and creating jobs. Each member of the firm has a background in the skilled-care industry and are acutely aware of the financial burden that plagues most people with a physical or mental disability.

Canada Benefit Group has discovered that thousands of Canadians are eligible for various Government benefits but are completely unaware. In particular one benefit, the Disability Tax Credit, can be claimed retroactively up to 10 years in the past.

Once a client retains them the team handles everything, including the application process, talking with doctors, accountants, negotiating with government agents and making sure eligibility criteria are being met.

For individuals who are curious but not ready for a phone consultation, they may go to the company’s website and use an easy-to-use calculator that estimates what they are entitled to if they are approved for the Disability Tax Credit.

The launch of the Disability Tax Credit disability tax credit calculator has been started to help those who need to receive their monies as soon as possible. The process can grant applicants up to $40,000.

For more information see the above URL.

Contact Info:
Name: Aaron Spiro
Email: Send Email
Organization: Canada Benefit Group
Address: 5475 Paré Street, Suite 252, Mount Royal, Quebec H4P 1P7, Canada
Phone: +1-888-511-2250
Website: https://www.canadabenefit.ca/

Source: PressCable

Release ID: 88955513

TNC Coin Enters the Market with Massive Bullish Price Movement

DUBAI, UNITED ARAB EMIRATES / ACCESSWIRE / Apirl 30, 2020 / TNC Coin (TNC) joined the cryptocurrency market with a blast. TNC initially listed on Hotbit, one of the leading exchanges in the industry and is now experiencing bullish price movement. After listing in Hotbit on April 2 8-29, 2020, TNC Coin experienced a massive price increase of more than 7500% for the TNC/BTC pair and more than 5000% for the TNC/ETH pair. TNC was featured in Hotbit's Top Rising section because of this increase.

For typical listing events, crypto projects experience a drop in price as token holders sell their assets as soon as the listing commences. This may be because of the ICO and IEO listing process that crypto projects employ. As a result, massive price drops happen right after their project lists. However, as seen on Hotbit, this is not the case with TNC Coin. Instead of a price drop, the market showed a very promising bullish movement.

The TNC listing process is different from normal listing strategies based on ICOs or IEOs. This new way of listing is an integral part of the crypto merger system formulated by TNC IT Group where they merge companies through the world's first massive Crypto M&A.

According to the TNC Coin team, this is only the beginning. TNC Coin is expected to list in 20 more top global crypto exchanges on May 1, 2020. The token is expected to have the same value in the next exchanges as the initial listing price in Hotbit. The TNC Coin team expects more bullish movements as the coin becomes available for trading in more exchanges and more users come in to trade TNC Coins.

TNC Coin dubs itself on its official website as "The Ultimate Blockchain for the Game Industry." It was first advertised as a blockchain dedicated to the needs of game developers where they can create their own game currency with real crypto value. This way, users can earn crypto as they play. While this was the initial plan, the TNC vision is much greater. According to the TNC Coin CEO Mr. Jason Jang, the mainnet that the TNC team will develop is "beyond what is currently available in the blockchain and crypto market as of now." The mainnet will be scalable and ready for expansion into other industries such as finance, logistics, real estate, and more industries. As the Crypto M&A project goes further, the mainnet will be targeting different industries based on the needs of merger companies.

To celebrate TNC's success, the TNC Coin team is also giving away 10,000,000 TNC Coins to users who want to participate in their airdrop event. The team published this airdrop event through the token project's official website: www.tnccoin.com.

Media contact

Company Name: TNC IT Group

City, State: Dubai, United Arab Emirates

Contact: Rohit M

Telephone: +971 561219967

Email: media@tncitgroup.com

Website: https://tncitgroup.com

SOURCE: TNC IT Group

ReleaseID: 587738

World High Life PLC Announces Issue of Equity

LONDON, ENGLAND / ACCESSWIRE / April 30, 2020 / World High Life Plc (LSE:LIFE)(OTCQB:WRHLF) announces that the Company has issued 960,000 ordinary shares of 1 pence each in the Company ("Ordinary Shares") in settlement of fees to certain advisors (including George St-Pierre Enterprises Inc.) of the Company in lieu of cash at a price per share of 10p.

The Company has also issued a further 2,231,650 Ordinary Shares in lieu of cash in respect of outstanding debt repayments at a price per share of 10p.

Application will be made for the new Ordinary Shares to be admitted to trading on the AQSE Growth Market and admission is expected to become effective, and dealings in the new Ordinary Shares are expected to commence, on 6 May 2020.

Following this issue, the Company's has 145,600,730 Ordinary Shares in issue, each share carrying the right to one vote. The figure of 145,600,730 should be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

The Directors of the Company accept responsibility for the contents of this announcement.

About Love Hemp

Love Hemp is one of the UK's leading CBD and Hemp product suppliers and has more than 40 product lines, comprising oils, sprays and vapes and a variety of edible and water-based CBD products. Love Hemp has established relationships with over 1,200 stores in the UK, including leading brands such as Ocado, Holland & Barrett and WH Smith.

About World High Life

World High Life was established by the founders of Supreme Cannabis (TSX: FIRE), and 1933 Industries (CSE: TGIF), both companies at the forefront of the legalized cannabis industry. LIFE was established to take advantage of the huge opportunities available in the UK and European legal cannabis space, which is set to be the largest in the world within five years.

For further information please contact:

David Stadnyk

Founder & CEO

World High Life PLC

+44 (0) 7926 397 675

info@worldhighlife.uk

 

 
 

AQSE Corporate Adviser

Mark Anwyl/Allie Feuerlein

Peterhouse Capital Limited

+44 (0) 20 7469 0930

ma@peterhousecap.com

af@peterhousecap.com

Financial PR

Camilla Horsfall/Megan Ray

Blytheweigh

+44 (0) 20 7138 3224

Camilla.horsfall@blytheweigh.com

Megan.Ray@blytheweigh.com

For more information on World High Life please visit: www.worldhighlife.uk

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

SOURCE: World High Life PLC

ReleaseID: 587694

Rigrodsky & Long, P.A. Files Class Action Suit Against Tetraphase Pharmaceuticals, Inc.

WILMINGTON, DE, / ACCESSWIRE / April 29, 2020 / Rigrodsky & Long, P.A. announces that it has filed a class action complaint in the United States District Court for the District of Delaware on behalf of holders of Tetraphase Pharmaceuticals, Inc. ("Tetraphase" or the "Company") (NASDAQ:TTPH) common stock in connection with the proposed acquisition of Tetraphase by AcelRx Pharmaceuticals, Inc. ("AcelRx") and Consolidation Merger Sub, Inc. ("Merger Sub"), announced on March 16, 2020 (the "Complaint"). The Complaint, which alleges violations of the Securities Exchange Act of 1934 against Tetraphase, its Board of Directors (the "Board"), AcelRx, and Merger Sub, is captioned Plumley v. Tetraphase Pharmaceuticals, Inc., Case No. 1:20-cv-00496 (D. Del.).

If you wish to discuss this action or have any questions concerning this notice or your rights or interests, please contact plaintiff's counsel, Seth D. Rigrodsky or Gina M. Serra at Rigrodsky & Long, P.A., 300 Delaware Avenue, Suite 1220, Wilmington, DE 19801, by telephone at (888) 969-4242, by e-mail at info@rl-legal.com, or at https://www.rigrodskylong.com/cases-tetraphase-pharmaceuticals-inc,join.

On March 15, 2020, Tetraphase entered into an agreement and plan of merger (the "Merger Agreement") with AcelRx and Merger Sub. Pursuant to the terms of the Merger Agreement, shareholders of Tetraphase will receive 0.6303 shares of AcelRx common stock and one contingent value right for each share of Tetraphase common stock they own (the "Proposed Transaction").

Among other things, the Complaint alleges that, in an attempt to secure shareholder support for the Proposed Transaction, defendants issued materially incomplete disclosures in a Form S-4 Registration Statement (the "Registration Statement") filed with the United States Securities and Exchange Commission. The Complaint alleges that the Registration Statement omits material information with respect to, among other things, the Company's and AcelRx's financial projections and the analyses performed by Tetraphase's financial advisor. The Complaint seeks injunctive and equitable relief and damages on behalf of holders of Tetraphase common stock.

If you wish to serve as lead plaintiff, you must move the Court no later than June 29, 2020. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Any member of the proposed class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.

Rigrodsky & Long, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.

Attorney advertising. Prior results do not guarantee a similar outcome.

CONTACT: 

Rigrodsky & Long, P.A.
Seth D. Rigrodsky
Gina M. Serra
(888) 969-4242 (Toll-Free)
(302) 295-5310
Fax: (302) 654-7530
info@rl-legal.com 
https://rl-legal.com

SOURCE: Rigrodsky & Long P.A.

ReleaseID: 587629

CLASS ACTION UPDATE for ALGN, VMW and LBRT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / April 29, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

ALGN Shareholders Click Here: https://www.zlk.com/pslra-1/align-technology-inc-loss-form-2?prid=6264&wire=1
VMW Shareholders Click Here: https://www.zlk.com/pslra-1/vmware-inc-loss-form?prid=6264&wire=1
LBRT Shareholders Click Here: https://www.zlk.com/pslra-1/liberty-oilfield-services-inc-loss-form?prid=6264&wire=1

* ADDITIONAL INFORMATION BELOW *

Align Technology, Inc. (NASDAQ:ALGN)

ALGN Lawsuit on behalf of: investors who purchased April 24, 2019 – July 24, 2019
Lead Plaintiff Deadline: May 1, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/align-technology-inc-loss-form-2?prid=6264&wire=1

According to the filed complaint, during the class period, Align Technology, Inc. made materially false and/or misleading statements and/or failed to disclose that: (a) Align was then experiencing a significant decline in demand for its products in the important Chinese market; (b) Chinese consumer sentiment towards the Company was deteriorating; and (c) as a result of the foregoing, Defendants' positive statements about Align and its businesses were lacking in a reasonable basis.

VMware, Inc. (NYSE:VMW)

VMW Lawsuit on behalf of: investors who purchased March 30, 2019 – February 27, 2020
Lead Plaintiff Deadline: June 1, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/vmware-inc-loss-form?prid=6264&wire=1

According to the filed complaint, during the class period, VMware, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) VMware's reporting with respect to its backlog of unfilled orders was not in compliance with all relevant accounting and disclosure requirements; (ii) the foregoing subjected the Company to a foreseeable risk of heightened regulatory scrutiny and/or investigation; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

Liberty Oilfield Services, Inc. (NYSE:LBRT)

LBRT Lawsuit on behalf of: investors who purchased securities pursuant and/or traceable to the documents issued in connection with the Company's January 2018 initial public offering.
Lead Plaintiff Deadline: June 2, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/liberty-oilfield-services-inc-loss-form?prid=6264&wire=1

According to the filed complaint, (1) there was an oversupply in the hydraulic fracturing services market; (2) the Company's pricing power was weak; (3) Liberty's services were not increasing and its competition was not decreasing; and (4) as a result, Defendants' statements about the Company's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 587721